Treatment of tachyarrhythmias of supraventricular origin
US5387613A · kind A · utility
26Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 23, 1993 |
| Grant date | Feb 7, 1995 |
| Priority date | — |
| Expiry date | Jul 23, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/135
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the treatment of tachyarrhythmias of supraventricular origin. This condition may safely be treated by nasal administration of a composition comprising propranolol dissolved in a pharmaceutically acceptable, aqueous-based carrier. A total dose of up to 20 mg of propranolol may be administered at one time.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.